Chipmaker Nvidia was recently present again at the J.P. Morgan Healthcare Conference. Nvidia is looking to tap into the growing tech and healthcare overlap and sees it as a billion-dollar-a-year business market. It is specifically focusing on the AI space with hopes of penetrating software-defined medical devices. Kimberley Powell, Vice President of Healthcare at Nvidia explained that “we recognize that healthcare is becoming the absolute largest data-generating industry and we have global challenges increasing the cost of healthcare delivery and access to healthcare. So we build computing platforms to serve these grand challenges”.

Powell went on to add how Nvidia chips are serving the healthcare market with applications in genomic discovery and AI all becoming prominent. One area was the brand tie-up with InstaDeep, which BioNTech has just acquired. The link-up saw the two feed AI models genetic data: the Gs, Ts, As, Cs and more that eventually get translated into our proteins. Using the DNA of hundreds of people, as well as Cambridge-1, the most powerful supercomputer in the U.K., the researchers found it was feasible to develop a generalizable program—a “genomic language model”.